The latest news in renal cancer
Bristol Myers Squibb (BMS) has announced that the National Institute for Health and Care Excellence…
Translocation renal cell carcinoma (tRCC) is a rare and aggressive form of kidney cancer. It…
One of the biggest challenges treating kidney cancer is the wide number of tumour types…
Patients with advanced renal cell carcinoma who received the checkpoint inhibitor combination nivolumab plus ipilimumab experienced longer treatment-free survival…
Children with kidney cancers continue to be diagnosed with larger and more advanced tumours in…
Researchers at the Francis Crick Institute, The Royal Marsden NHS Foundation Trust, UK, and UCL,…
In a new single-arm study, researchers at The University of Texas MD Anderson Cancer Center,…
A targeted drug has shown promising activity against brain metastases resulting from kidney cancer, achieving…
In a recent study, researchers highlighted immediate cardiopulmonary risks associated with patients undergoing minimally invasive…
Using an existing drug for late-stage kidney cancer at an earlier stage of the disease…